User banner image
User avatar
  • admin

Posts

Novo Nordisk A/S: The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is cleared to close

Bagsværd, Denmark, 14 December 2024 — As of today, all regulatory closing conditions relating to the review of Novo Holdings A/S’s pending acquisition of Catalent, Inc....

AFK Journey Nominated “Mobile Game of the Year” by The Game Awards and Named Best Game of 2024 by Google Play and the Apple App Store

Multiple Award Wins, Nominations, and Accolades Spotlight the Success of Farlight Games and Lilith Games’ Free-To-Play Fantasy RPG SHANGHAI, Dec. 13, 2024 (GLOBE NEWSWIRE) —...

Discover the Beauty of Nature This Holiday Season with the Bird Buddy Smart Bird Feeder PRO

ORLANDO, Fla., Dec. 13, 2024 (GLOBE NEWSWIRE) — Nature has a way of captivating us, whether through the vibrant colors of a cardinal or the...

A Toronto Winter Market for People and Planet

Charity-run market at Evergreen Brick Works showcases artisan and vintage goods, local food vendors and festive activities for all ages TORONTO, ONTARIO, Dec. 13, 2024...

United States Cosmetic Pigments Market, Competition, Forecast Report 2024-2029, with Key Players Clariant, Kobo Products, Merck, LANXESS, BASF, Sun Chemical and Sensient Cosmetic Technologies

Dublin, Dec. 13, 2024 (GLOBE NEWSWIRE) — The “United States Cosmetic Pigments Market, By Region, Competition, Forecast and Opportunities, 2019-2029F” report has been added to...

Algae Skincare Products Market Share, Trends, Opportunity and Forecasts to 2029

Key Market Trends include Integration of Algae with Other Natural Ingredients, Personalized and Customized Skincare Solutions, Focus on Eco-Friendly Packaging and Sustainability and Increased Emphasis...

Rakovina Therapeutics Announces Closing of Oversubscribed $3M Private Placement

VANCOUVER, British Columbia, Dec. 13, 2024 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”, “Rakovina”, or “Rakovina Therapeutics”) a biopharmaceutical company committed to...

Checkpoint Therapeutics Announces FDA Approval of UNLOXCYT™ (cosibelimab-ipdl)

UNLOXCYT is the first and only FDA-approved anti-PD-L1 treatment for advanced cutaneous squamous cell carcinoma WALTHAM, Mass., Dec. 13, 2024 (GLOBE NEWSWIRE) — Checkpoint Therapeutics,...

NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares

NAARDEN, The Netherlands and MIAMI, Dec. 13, 2024 (GLOBE NEWSWIRE) — NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS; “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical...

Nova Leap Health Corp. provides update on Special Meeting

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Dec. 13, 2024 (GLOBE NEWSWIRE) — NOVA LEAP...